A client taking weekly semaglutide after a recent dose escalation reports persistent vomiting and severe early satiety and is scheduled for an elective procedure under deep sedation tomorrow. Which actions are appropriate? Select all that apply.
Select All That Apply
Choose your responses, then check the answer.
Explanation
Persistent upper-gastrointestinal symptoms increase concern for delayed gastric emptying, dehydration, and aspiration during deep sedation. The procedural, anesthesia, and prescribing teams should use an individualized plan; routine fasting or a fixed self-directed withholding interval does not replace reassessment.
Quick answer Escalate the symptoms and medication history, assess dehydration and abdominal status, clarify ongoing semaglutide therapy, and follow a documented individualized procedural plan.
Why this is correct The current semaglutide label reports pulmonary aspiration during general anesthesia or deep sedation and does not recommend use in severe gastroparesis. Multi-society guidance emphasizes symptom- and risk-based shared decisions rather than a universal hold interval.
Easy analogy or mental picture Fasting is a clock, but gastric emptying is the conveyor belt. Severe symptoms suggest the belt may still be stalled even when the fasting clock has run out.
Memory hook Severe GI symptoms plus deep sedation: disclose, assess, individualize, and reassess.
NCLEX decision rule Do not apply a one-size-fits-all drug hold or assume fasting erases aspiration risk. In an elective case with persistent vomiting, bring the anesthesia, procedural, and prescribing teams into the decision before proceeding.
Why the other choices are wrong A 24-hour liquid diet, a fixed 7-day hold, a normal point-of-care glucose, or temporary symptom relief cannot by themselves prove an empty stomach or make deep sedation safe.
References
1DailyMed: OZEMPIC (semaglutide), revised May 2026Severe gastroparesis, delayed gastric emptying, and aspiration during deep sedation
2Multi-society GLP-1 Perioperative Clinical Practice GuidanceIndividualized risk assessment instead of a universal withholding interval
3ASA: Diabetes or Weight-Loss Drugs Before SurgeryCurrent patient-facing precautions for gastrointestinal symptoms and deep sedation
Semaglutide and deep-sedation riskBalance therapeutic continuity against symptomatic delayed gastric emptying, dehydration, and aspiration risk through a documented shared plan.